Omeros Corporation
NASDAQ:OMERBiotechnology
Healthcare
$14.55 +4.46%
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
52W Low $2.95High $17.65
Volume 2.53M
Average 1.55M
Balance Sheet
Inspect the capital base behind the business.
Assets
$325.63M
FY 2025 · Annual
+17.5% YoYLiabilities
$446.86M
FY 2025 · Annual
-2.8% YoYEquity
-$121.23M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 100.81M | 11.01M | 7.11M | 3.4M | 9.66M |
| Short-term Investments | 56.46M | 183.91M | 164.74M | 86.73M | 162.14M |
| Net Receivables | 82.47M | 242.02M | 6.72M | 36.82M | 36.27M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 67K | 6.3M | 30.75M | 7.17M | 7.6M |
| Total Current Assets | 247.96M | 443.24M | 217.9M | 134.12M | 215.67M |
| Property, Plant & Equipment (Net) | 30.01M | 23.25M | 20.58M | 17.64M | 12.48M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 141.31M | 124.48M | 139.79M | 125.32M | 97.49M |
| Total Non-current Assets | 171.31M | 147.73M | 160.37M | 142.96M | 109.97M |
| Total Assets | 419.27M | 590.97M | 378.27M | 277.08M | 325.63M |
| Account Payables | 13.4M | 5.99M | 7.71M | 5.91M | 4.76M |
| Short-term Debt | 0 | 94.38M | 8.58M | 21M | 17.06M |
| Tax Payables | 338K | 4.87M | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 2.47M |
| Other Current Liabilities | 3.71M | 7.82M | 0 | 29.51M | 30.9M |
| Total Current Liabilities | 51.79M | 136.38M | 53.32M | 79.53M | 78.06M |
| Long-term Debt | 313.46M | 220.91M | 329.71M | 166.58M | 208.54M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.12M | 125.57M | 2.09M | 200.11M | 153.02M |
| Total Non-current Liabilities | 343.7M | 368.9M | 349.94M | 380.16M | 368.8M |
| Total Liabilities | 395.49M | 505.29M | 403.25M | 459.69M | 446.86M |
| Common Stock | 626K | 628K | 611K | 580K | 716K |
| Retained Earnings | (683.13M) | (635.72M) | (753.53M) | (910.35M) | (913.7M) |
| Accumulated OCI | 0 | 0 | (0) | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 23.78M | 85.68M | (24.98M) | (182.61M) | (121.23M) |
| Total Debt | 347.84M | 342.02M | 361.58M | 207.02M | 239.14M |
| Net Debt | 247.03M | 331.01M | 354.48M | 203.62M | 229.48M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $1.9M |
| Short-term Investments | $133.4M |
| Receivables | $37.5M |
| Inventory | $183.0K |
| Other Current | $7.3M |
| Total Current Assets | $180.4M |
| PP&E (Net) | $11.0M |
| Long-term Investments | $94.8M |
| Total Non-current Assets | $105.8M |
| Total Assets | $286.2M |
Analysis
Selected assets total $286.2M for Latest. The largest visible component is Short-term Investments at $133.4M, about 46.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 24, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 1, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 28, 2026 |
How much cash does OMER have?
Omeros Corporation (OMER) reported $9.66M in cash and equivalents in fiscal 2025.
How much debt does OMER carry?
Omeros Corporation (OMER) reported $239.14M of total debt, with net debt of $229.48M.
Continue the stock analysis
Jump to another research area for this company.